ERBB2 and breast carcinoma: A total of 104 breast cancer patients were divided into different groups based on age, primary tumor size, pathological stage, cell differentiation, metastatic lymph node number, status of hormone receptor, the expression of Her2 and other clinical parameters, and were compared with each other in each group.